<DOC>
	<DOCNO>NCT01224626</DOCNO>
	<brief_summary>To collect efficacy safety information subject treat Zyvox ( linezolid ) vancomycin resistance Enterococcus faecium infection appropriate use daily practice .</brief_summary>
	<brief_title>Zyvox ( Linezolid ) Special Investigation For Vancomycin-Resistant Enterococci ( VRE )</brief_title>
	<detailed_description />
	<mesh_term>Linezolid</mesh_term>
	<mesh_term>Vancomycin</mesh_term>
	<criteria>Subject Zyvox ( linezolid ) administer . Infected subject Vancomycin resistance Enterococcus faecium . Infected subject MRSA organism .</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2012</verification_date>
	<keyword>VRE</keyword>
	<keyword>Japanese</keyword>
	<keyword>Post Marketing Surveillance</keyword>
</DOC>